Pennsylvania Superior Court Affirms $4M Verdict in Topamax Case

Janssen Pharmaceuticals Set to Face More Trials Over Risperdal
August 19, 2015
New York Woman Receives Largest Settlement for Personal Injury Case in NY State History
August 26, 2015

Helen Jones
Executive Vice President 

A split panel of judges ruled to affirm the $4M jury verdict in Czimmer v. Janssen Pharmaceuticals, which was delivered in 2013 against Janssen Pharmaceuticals in connection with their anti-seizure medication Topamax. The original claim was brought by a mother claiming that her use of Topamax led to birth defects in her son. After being awarded the $4M verdict, with $3.4M being for pain and suffering, Janssen appealed that the jury award violated state law and that preemption should have barred the plaintiff’s state claim of failure-to-warn. The three-judge panel, split 2-1, ruled that there was no violation of state law that should have barred the verdict, and looked to recent precedent to dismiss the preemption claim.

Plaintiff Support offers a variety of settlement funding services to help plaintiffs and attorneys during and after a personal injury case. Learn more about how we can help you.

Comments are closed.